[go: up one dir, main page]

WO2002001228A8 - Interaction d'especes immobilisees sur des colloides avec des especes sur des structures non colloidales - Google Patents

Interaction d'especes immobilisees sur des colloides avec des especes sur des structures non colloidales

Info

Publication number
WO2002001228A8
WO2002001228A8 PCT/US2001/020168 US0120168W WO0201228A8 WO 2002001228 A8 WO2002001228 A8 WO 2002001228A8 US 0120168 W US0120168 W US 0120168W WO 0201228 A8 WO0201228 A8 WO 0201228A8
Authority
WO
WIPO (PCT)
Prior art keywords
species
colloid
interaction
immobilized
colloidal structures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/020168
Other languages
English (en)
Other versions
WO2002001228A2 (fr
Inventor
Cynthia C Bamdad
R Shoshana Bamdad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Minerva Biotechnologies Corp
Original Assignee
Minerva Biotechnologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minerva Biotechnologies Corp filed Critical Minerva Biotechnologies Corp
Priority to EP01948690A priority Critical patent/EP1309858A2/fr
Priority to JP2002506110A priority patent/JP2004512497A/ja
Priority to CA002413932A priority patent/CA2413932A1/fr
Priority to AU7014001A priority patent/AU7014001A/xx
Publication of WO2002001228A2 publication Critical patent/WO2002001228A2/fr
Anticipated expiration legal-status Critical
Publication of WO2002001228A8 publication Critical patent/WO2002001228A8/fr
Ceased legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001—Enzyme electrodes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001—Enzyme electrodes
    • C12Q1/004—Enzyme electrodes mediator-assisted
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G01N33/5438—Electrodes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2610/00—Assays involving self-assembled monolayers [SAMs]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Nanotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Composite Materials (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Materials Engineering (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PCT/US2001/020168 2000-06-23 2001-06-25 Interaction d'especes immobilisees sur des colloides avec des especes sur des structures non colloidales Ceased WO2002001228A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP01948690A EP1309858A2 (fr) 2000-06-23 2001-06-25 Interaction d'especes immobilisees sur des colloides avec des especes sur des structures non colloidales
JP2002506110A JP2004512497A (ja) 2000-06-23 2001-06-25 コロイドが固定された種と非コロイド構造上の種との相互作用
CA002413932A CA2413932A1 (fr) 2000-06-23 2001-06-25 Interaction d'especes immobilisees sur des colloides avec des especes sur des structures non colloidales
AU7014001A AU7014001A (en) 2000-06-23 2001-06-25 Interaction of colloid-immobilized species with species on non-colloidal structures

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60277800A 2000-06-23 2000-06-23
US09/602,778 2000-06-23

Publications (2)

Publication Number Publication Date
WO2002001228A2 WO2002001228A2 (fr) 2002-01-03
WO2002001228A8 true WO2002001228A8 (fr) 2003-03-06

Family

ID=24412766

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/020168 Ceased WO2002001228A2 (fr) 2000-06-23 2001-06-25 Interaction d'especes immobilisees sur des colloides avec des especes sur des structures non colloidales

Country Status (5)

Country Link
EP (1) EP1309858A2 (fr)
JP (1) JP2004512497A (fr)
AU (1) AU7014001A (fr)
CA (1) CA2413932A1 (fr)
WO (1) WO2002001228A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7615340B2 (en) 2000-10-03 2009-11-10 Minerva Biotechnologies Corporation Electronic detection of interaction and detection of interaction based on the interruption of flow
DE10109777A1 (de) * 2001-03-01 2002-09-19 Infineon Technologies Ag Verfahren zum Erfassen von makromolekularen Biopolymeren mittels mindestens einer Einheit zum Immobilisieren von makromolekularen Biopolymeren
DE10214719A1 (de) * 2002-04-03 2003-11-20 Infineon Technologies Ag Sensor zur qualitativen und quantitativen Bestimmung von (bio)organischen Oligomeren und Polymeren, Analyseverfahren hierzu sowie Verfahren zur Herstellung des Sensors
GB2391230A (en) * 2002-07-26 2004-02-04 Smartbead Technologies Ltd Multiparameter assays using coded supports
WO2004035195A2 (fr) 2002-10-18 2004-04-29 The University Of Iowa Research Foundation Electrodes modifiees d'un point de vue magnetique contenant au moins un element catalytique qui joue un role dans le processus de transfert de particules subatomiques
US7919332B2 (en) 2003-03-14 2011-04-05 Kitakyushu Foundation For The Advancement Of Industry Science And Technology Biological molecule-immobilized chip and its use
JP4441537B2 (ja) 2003-11-29 2010-03-31 プロテオゲン インコーポレイテッド インテグリン拮抗物質の超高速大量探索方法及びそれによる新規ペプチド
JP4941551B2 (ja) * 2007-03-30 2012-05-30 富士通株式会社 有機物質検出デバイス及びその製造方法
SE532583C2 (sv) * 2008-04-24 2010-02-23 Svanova Biotech Ab Guldinnehållande molekylaggregat för detektering av kemiska- och biokemiska specier
WO2018111941A1 (fr) * 2016-12-12 2018-06-21 13.8, Inc. Compositions de réactifs à haute affinité et leurs procédés d'utilisation
EP3460472B1 (fr) * 2017-09-22 2024-09-18 Nokia Technologies Oy Particules fonctionnalisées
EP3593708B1 (fr) 2018-07-13 2024-08-28 Nokia Technologies Oy Peau artificielle
CN110078829B (zh) * 2019-04-29 2021-01-15 大连理工大学 一种基于乙烯基砜表面反应的组氨酸标签蛋白定点共价固定方法
WO2021210189A1 (fr) * 2020-04-18 2021-10-21 有限会社マイテック Substrat en phase solide de cristal quantique de pathogène et procédé de comptage par fluorescence en phase solide de cristal quantique
US11609229B2 (en) * 2020-04-30 2023-03-21 Mytech Co. Ltd. Fluorescence counting system for quantifying viruses or antibodies on an immobilized metal substrate by using an antigen-antibody reaction
WO2021263227A2 (fr) 2020-06-26 2021-12-30 Minerva Biotechnologies Corporation Anticorps anti-nme et méthode de traitement du cancer ou de métastases cancéreuses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0750112B2 (ja) * 1988-04-26 1995-05-31 日本電信電話株式会社 レーザ磁気免疫測定方法を実施するための検体調整方法
IL85137A (en) * 1987-01-21 1992-02-16 Ares Serono Res & Dev Ltd Method of assaying for a ligand using surface plasmon resonance effect
US5369036A (en) * 1992-07-02 1994-11-29 Becton, Dickinson And Company Enhancement of signal in immunoassays using microparticles which contain different detectable substances
JPH1132764A (ja) * 1997-07-14 1999-02-09 Yakult Honsha Co Ltd ビフィドバクテリウム・ブレーベ用モノクローナル抗体

Also Published As

Publication number Publication date
WO2002001228A2 (fr) 2002-01-03
JP2004512497A (ja) 2004-04-22
AU7014001A (en) 2002-01-08
CA2413932A1 (fr) 2002-01-03
EP1309858A2 (fr) 2003-05-14

Similar Documents

Publication Publication Date Title
AU2001231752A1 (en) Cook-top
AU2001280599A1 (en) Compounds and methods
AU2001253418A1 (en) Compounds and methods
AU2001278755A1 (en) Injections
AU2001231682A1 (en) Surfactant combination
AU2002219135A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors
AU2001266345A1 (en) Five-membered-ring compound
WO2002001228A8 (fr) Interaction d'especes immobilisees sur des colloides avec des especes sur des structures non colloidales
AU2001265871A1 (en) Substituted sulfonylaminopyrimidines
AU2001258255A1 (en) Substituted benzoylcyclohexenones
AU2001254731A1 (en) Substituted phenyluracils
AUPQ872300A0 (en) Compounds and methods
AU2002213429A1 (en) Antiviral methods and compounds
AU4089601A (en) Panel
AU2001280039A1 (en) Ornamental panel
AU2001278951A1 (en) Compounds and methods
AU2000231564A1 (en) Phosphororganic compounds and the use thereof
AU2002223604A1 (en) Substituted phenyluracils
AU2002221918A1 (en) Soundproof floor-filling structure
AUPQ505800A0 (en) Structural assemblies
AU2002215021A1 (en) Fastening element
AU2001249886A1 (en) High q structure
AU2000235471A1 (en) Case with split panels
AU2000261825A1 (en) Protruding structure block
AU3816400A (en) Structure

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 2001270140

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2413932

Country of ref document: CA

ENP Entry into the national phase in:

Ref country code: JP

Ref document number: 2002 506110

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2001948690

Country of ref document: EP

D17 Declaration under article 17(2)a
WWP Wipo information: published in national office

Ref document number: 2001948690

Country of ref document: EP